BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 10925355)

  • 1. Androgen receptor CAG repeat length and risk of biliary tract cancer and stones.
    Meyer TE; O'Brien TG; Andreotti G; Yu K; Li Q; Gao YT; Rashid A; Shen MC; Wang BS; Han TQ; Zhang BH; Niwa S; Fraumeni JF; Hsing AW
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):787-93. PubMed ID: 20200439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative association between androgen receptor gene CAG repeat polymorphism and polycystic ovary syndrome? A systematic review and meta-analysis.
    Wang R; Goodarzi MO; Xiong T; Wang D; Azziz R; Zhang H
    Mol Hum Reprod; 2012 Oct; 18(10):498-509. PubMed ID: 22695532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flutamide metformin for post-menarcheal girls with preclinical ovarian androgen excess: evidence for differential response by androgen receptor genotype.
    Ong KK; de Zegher F; López-Bermejo A; Dunger DB; Ibáñez L
    Eur J Endocrinol; 2007 Nov; 157(5):661-8. PubMed ID: 17984247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor gene and sex-specific Alzheimer's disease.
    Ferrari R; Dawoodi S; Raju M; Thumma A; Hynan LS; Maasumi SH; Reisch JS; O'Bryant S; Jenkins M; Barber R; Momeni P
    Neurobiol Aging; 2013 Aug; 34(8):2077.e19-20. PubMed ID: 23545426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen/Androgen Receptor Signaling in Ovarian Cancer: Molecular Regulation and Therapeutic Potentials.
    Chung WM; Chen L; Chang WC; Su SY; Hung YC; Ma WL
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Androgen Receptor Signaling in Ovarian Cancer.
    Mizushima T; Miyamoto H
    Cells; 2019 Feb; 8(2):. PubMed ID: 30791431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the androgen receptor in ovarian cancer carcinogenesis and its clinical implications.
    Zhu H; Zhu X; Zheng L; Hu X; Sun L; Zhu X
    Oncotarget; 2017 Apr; 8(17):29395-29405. PubMed ID: 27741511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The androgen receptor cytosine-adenine-guanine repeat length contributes to the development of epithelial ovarian cancer.
    Meng X; Lu P; Chu Z; Fan Q
    Oncotarget; 2016 Jan; 7(2):2105-12. PubMed ID: 26556855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set.
    Beesley J; Jordan SJ; Spurdle AB; Song H; Ramus SJ; Kjaer SK; Hogdall E; DiCioccio RA; McGuire V; Whittemore AS; Gayther SA; Pharoah PD; Webb PM; Chenevix-Trench G; ; ;
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2557-65. PubMed ID: 18086758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk.
    Terry KL; De Vivo I; Titus-Ernstoff L; Shih MC; Cramer DW
    Cancer Res; 2005 Jul; 65(13):5974-81. PubMed ID: 15994977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years.
    Spurdle AB; Dite GS; Chen X; Mayne CJ; Southey MC; Batten LE; Chy H; Trute L; McCredie MR; Giles GG; Armes J; Venter DJ; Hopper JL; Chenevix-Trench G
    J Natl Cancer Inst; 1999 Jun; 91(11):961-6. PubMed ID: 10359549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor gene methylation and exon one CAG repeat length in ovarian cancer: differences from breast cancer.
    Kassim S; Zoheiry NM; Hamed WM; Going JJ; Craft JA
    IUBMB Life; 2004 Jul; 56(7):417-26. PubMed ID: 15545219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk?
    Zeegers MP; Kiemeney LA; Nieder AM; Ostrer H
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1765-71. PubMed ID: 15533905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series.
    Levine DA; Boyd J
    Cancer Res; 2001 Feb; 61(3):908-11. PubMed ID: 11221880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor exon 1 CAG repeat length and risk of ovarian cancer.
    Spurdle AB; Webb PM; Chen X; Martin NG; Giles GG; Hopper JL; Chenevix-Trench G
    Int J Cancer; 2000 Sep; 87(5):637-43. PubMed ID: 10925355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphic CAG repeat length within the androgen receptor gene: identification of a subgroup of patients with increased risk of ovarian cancer.
    Santarosa M; Bidoli E; Gallo A; Steffan A; Boiocchi M; Viel A
    Oncol Rep; 2002; 9(3):639-44. PubMed ID: 11956643
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.